Management of high risk non-muscle invasive bladder cancer: is re-resection always essential?

被引:0
|
作者
Bangash, H. [1 ]
Lozinskiy, M. [2 ]
Hayne, D. [1 ,3 ]
机构
[1] Fiona Stanley Hosp, Murdoch, WA, Australia
[2] Rockingham Gen Hosp, Rockingham, Australia
[3] Univ Western Australia, Sch Surg, Crawley, Australia
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:18 / 18
页数:1
相关论文
共 50 条
  • [21] Value of hexaminolevulinate fluorescent cystoscopy and resection in the management of non-muscle invasive bladder cancer
    Tomescu, P. I.
    Dragoescu, P. O.
    Enache, M. A.
    Maria, C.
    Panus, A.
    Dragoescu, N. A.
    Enache, S. D.
    Plesea, I. E.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E958 - U13
  • [22] Genomic characterization of high-risk non-muscle invasive bladder cancer
    Meeks, Joshua J.
    Carneiro, Benedito A.
    Pai, Sachin G.
    Oberlin, Daniel T.
    Rademaker, Alfred
    Fedorchak, Kyle
    Balasubramanian, Sohail
    Elvin, Julia
    Beaubier, Nike
    Giles, Francis J.
    ONCOTARGET, 2016, 7 (46) : 75176 - 75184
  • [23] The Promise of Radiotherapy in High-Risk Non-Muscle Invasive Bladder Cancer
    Bola, Becky
    Hoskin, Peter J.
    Sangar, Vijay
    Choudhury, Ananya
    CANCERS, 2025, 17 (04)
  • [24] Pembrolizumab monotherapy for high-risk, non-muscle invasive bladder cancer
    Balar, Arjun, V
    Kamat, Ashish M.
    de Wit, Ronald
    LANCET ONCOLOGY, 2021, 22 (09): : E380 - E380
  • [25] Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer
    Bashir Al Hussein Al Awamlh
    Sam S. Chang
    Current Oncology Reports, 2023, 25 : 83 - 91
  • [26] The long term outcome of high risk non-muscle invasive bladder cancer
    Thomas, F.
    Rubin, N.
    Goepel, J.
    Abbod, M. F.
    Rosario, D.
    Catto, J. W. F.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E965 - U26
  • [27] Value of Fluorescence Cystoscopy in High Risk Non-muscle Invasive Bladder Cancer
    Mayr, Roman
    Burger, Maximilian
    CURRENT UROLOGY REPORTS, 2013, 14 (02) : 90 - 93
  • [28] Value of Fluorescence Cystoscopy in High Risk Non-muscle Invasive Bladder Cancer
    Roman Mayr
    Maximilian Burger
    Current Urology Reports, 2013, 14 : 90 - 93
  • [29] Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer
    Al Awamlh, Bashir Al Hussein
    Chang, Sam S.
    CURRENT ONCOLOGY REPORTS, 2023, 25 (02) : 83 - 91
  • [30] Long-term Outcomes from Re-resection for High-risk Non-muscle-invasive Bladder Cancer: A Potential to Rationalize Use
    Gordon, Patrick C.
    Thomas, Francis
    Noon, Aidan P.
    Rosario, Derek J.
    Catto, James W. F.
    EUROPEAN UROLOGY FOCUS, 2019, 5 (04): : 650 - 657